CD26-antigen-inhibitors/metforminBullous pemphigoid: 28 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1778卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70926-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：123 / 123

相关论文

共 16 条

[1] CD26-antigen-inhibitors/metformin/pasireotideHyperglycaemia and treatment failure: case report
Reactions Weekly, 2021, 1840 (1) : 112 - 112
[2] CD26 antigen inhibitorsBullous pemphigoid: 5 case reports
Reactions Weekly, 2018, 1697 (1) : 106 - 106
[3] CD26 antigen inhibitorsBullous pemphigoid: 8 case reports
Reactions Weekly, 2019, 1750 (1) : 72 - 72
[4] CD26-antigen-inhibitorsBullous pemphigoid: 17 case reports
Reactions Weekly, 2020, 1819 (1) : 77 - 77
[5] Dipeptidyl peptidase-4 inhibitors/metforminBullous pemphigoid: 5 case reports
Reactions Weekly, 2018, 1699 (1) : 101 - 101
[6] Sitagliptin/vildagliptin/metforminBullous pemphigoid: 3 case reports
Reactions Weekly, 2013, 1448 (1) : 28 - 28
[7] This Month in JAAD Case Reports: May 2023: Janus kinase inhibitors for bullous pemphigoid
Sloan, Brett
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1004 - 1004
[8] Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26
Nguyen, C
Blanco, J
Mazaleyrat, JP
Krust, B
Callebaut, C
Jacotot, E
Hovanessian, AG
Wakselman, M
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2100 - 2110
[9] Antineoplastics/Cd223-antigen-inhibitorsChronic active gastritis and focal enhancing gastritis: 12 case reports
Reactions Weekly, 2019, 1780 (1) : 40 - 40
[10] Axicabtagene ciloleucelCytokine release syndrome and development of drug resistance due to loss of CD19 antigen: 2 case reports
Reactions Weekly, 2019, 1777 (1) : 47 - 47